RIXUBIS [Coagulation Factor IX (Recombinant)] is an antihemophilic factor indicated for adults and children with hemophilia B and for:
- Control and prevention of bleeding episodes
- Perioperative management
- Routine prophylaxis
RIXUBIS is not indicated for induction of immune tolerance in patients with Hemophilia B.
For full prescribing, dosing and other information, please refer to the prescribing information linked below.